# Efficacy and Safety of Minodronate in Patients With Low Back Pain

> **NCT05645289** · PHASE4 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Minodronate
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT05645289
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-04-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645289, "Efficacy and Safety of Minodronate in Patients With Low Back Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05645289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*